%0 Journal Article
%T Delivery and postpartum management of a patient with Pompe disease: Case report and review of the literature
%A Batuhan Turgay
%A Feride Soylemez
%A Kazibe Koyuncu
%A Rusen Aytac
%J Archive of "Obstetric Medicine".
%D 2017
%R 10.1177/1753495X16688601
%X Pompe disease is an autosomal-recessive disorder caused by acid alpha-glucosidase deficiency due to mutations in the GAA gene. There are two forms of the disease: infantile-onset Pompe disease and late-onset Pompe disease. The worldwide incidence of both forms of the disease is commonly reported to be 1 in 40,000. Adult patients are affected by limb-girdle muscular weakness and respiratory insufficiency. Enzyme replacement therapy with alglucosidase-alpha is available since 2006. There is little knowledge about pregnant woman with Pompe disease. These women should be considered as high-risk pregnant women. Here, we aim to present Cesarean delivery and postpartum management of a case with an interrupted enzyme replacement therapy during pregnancy
%K Perinatal medicine
%K complications
%K Pompe disease
%K delivery
%K postpartum management
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637993/